BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: Implications for melanoma staging and adjuvant therapy
Barbour, Andrew P., Tang, Yue Hang, Armour, Nicola, Dutton-Regester, Ken, Krause, Lutz, Loffler, Kelly A., Lambie, Duncan, Burmeister, Bryan, Thomas, Janine, Smithers, B. Mark, Hayward, Nicholas K.Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2014.06.009
Date:
October, 2014
File:
PDF, 626 KB
english, 2014